Hidden in plain sight: HIV, antiretrovirals, and stillbirths

The Lancet

Volumn 387, Issue 10032, 2016, Pages 1994-1995

  Shapiro, Roger ^a,d   Dryden Peterson, Scott ^a,d   Powis, Kate ^a,c,d   Zash, Rebecca ^a,d   Lockman, Shahin ^a,b,d  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

^d PRINCESS MARINA HOSPITAL   (Botswana)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; NEVIRAPINE;

AFRICAN; CONCEPTION; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LETTER; PANDEMIC; PREGNANCY; PRIORITY JOURNAL; RISK ASSESSMENT; STILLBIRTH; EPIDEMIOLOGY; FEMALE;

FEMALE; HUMANS; PREGNANCY; STILLBIRTH;

EID: 84967321380     PISSN: 01406736     EISSN: 1474547X     Source Type: Journal    
DOI: 10.1016/S0140-6736(16)30459-7     Document Type: Letter

References (5)

1. H Blencowe, S Cousens, FB Jassir et al. National, regional, and worldwide estimates of stillbirth rates in 2015, with trends from 2000: a systematic analysis Lancet Glob Health 4 2016 e98 108
2. JE Lawn, H Blencowe, P Waiswa et al. Stillbirths: rates, risk factors, and acceleration towards 2030 Lancet 387 2016 587 603
3. UNAIDS UNAIDS global factsheets 2014 http://www.unaids.org/sites/default/files/en/media/unaids/contentassets/documents/factsheet/2014/20140716-FactSheet-en.pdf 2014 (accessed March 17, 2016).
4. CO Wedi, S Kirtley, S Hopewell, R Corrigan, SH Kennedy, J Hemelaar Perinatal outcomes associated with maternal HIV infection: a systematic review and meta-analysis Lancet HIV 3 2016 e33 e48
5. JY Chen, HJ Ribaudo, S Souda et al. Highly active antiretroviral therapy and adverse birth outcomes among HIV-infected women in Botswana J Infect Dis 206 2012 1695 1705